Higher interleukin-6 is associated with greater momentary social connection in close relationships in daily life

Psychoneuroendocrinology. 2024 Jun:164:107020. doi: 10.1016/j.psyneuen.2024.107020. Epub 2024 Mar 8.

Abstract

Recent evidence has documented associations between higher levels of inflammation and social approach behaviors toward close others in laboratory-based tasks. Yet it is unknown if this translates to interactions with close others in daily life. Given that momentary experiences of social connection have both relational and health consequences, this is a critical gap in our knowledge. To address the association between inflammation and momentary social connection experiences in close relationships, 55 participants provided blood samples on two consecutive days, which were assayed for circulating levels of the inflammatory marker interleukin-6 (IL-6). After providing the first blood sample, participants received the annual influenza vaccine as a mild inflammatory challenge. Participants also reported on cognitive, affective, and behavioral indicators of social connection with a specific close other multiple times across the two study days. Results indicated that levels of IL-6 were positively associated with temporally-proximal indicators of momentary social connection with a close other. Specifically, higher levels of IL-6 were associated with greater feelings of comfort from the close other, greater desire to be near them, and higher reported relationship quality. Greater IL-6 reactivity to the vaccine was only associated with increased reported relationship quality. These data add to the existing literature suggesting that higher levels of IL-6 may motivate social approach toward a close other, extending evidence to now include momentary social connection experiences in daily life.

Keywords: Close relationships; Inflammation; Interleukin-6; Social approach; Social connection.

MeSH terms

  • Emotions
  • Humans
  • Inflammation
  • Influenza Vaccines*
  • Interleukin-6*
  • Social Behavior

Substances

  • Influenza Vaccines
  • Interleukin-6
  • IL6 protein, human